Real-time enrollment status for this myelofibrosis clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 12:07 PM UTC
| NCT Number | NCT05980806 |
| Recruiting Status | Recruiting |
| Condition | Myelofibrosis |
| Phase | Clinical Trial |
| Target Enrollment | 118 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Karyopharm Therapeutics Inc |
| Last Updated on CT.gov | February 12, 2026 (2 weeks ago) |
As of March 2, 2026: Clinical trial NCT05980806 is currently recruiting participants. This clinical trial study for myelofibrosis is actively seeking new participants at 6 locations across the United States. The study is sponsored by Karyopharm Therapeutics Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05980806 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05980806 was last updated 2 weeks ago (February 12, 2026). HelloStudys verifies this status automatically.